We already have a 2-in-1 high blood pressure/high cholesterol drug on the market, called Caduet, but now the FDA has approved a 3 in 1, called Exforge HCT. The new pill is a combination of a calcium channel blocker, angiotensin receptor blocker and diuretic – so-called water pills.

Here is the press release issued by the manufacturer, Novartis:
FDA approves Exforge HCT(R) – the Only High Blood Pressure Treatment to Combine Three Medications in a Single Pill
EAST HANOVER, N.J., April 30 /PRNewswire/ — The US Food and Drug Administration (FDA) has approved Exforge HCT (amlodipine, valsartan, hydrochlorothiazide), the only blood pressure (BP) …read more

And yet another link to Alzheimer’s disease from another chronic disease process… It seems that anti-hypertensives have proven to benefit in the prevention and treatment of Alzheimer’s disease. Such implications could aid in the ultimate cure and care of this dreadful mind altering disease. Just what anti-hypertensives made the list?
…significantly benefit from the treatment with the anti-hypertensive agent Valsartan, found to pharmacologically prevent beta-amyloid production in the brain even when delivered to Alzheimer’s disease mice at doses 3-4 fold lower than the minimal equivalent dose prescribed for the treatment of hypertension in humans. Other anti-hypertension drugs with beneficial …read more